159 related articles for article (PubMed ID: 22936391)
1. Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer.
Heusinger K; Jud SM; Häberle L; Hack CC; Fasching PA; Meier-Meitinger M; Lux MP; Hagenbeck C; Loehberg CR; Wittenberg T; Rauh C; Wagner F; Uder M; Hartmann A; Schulz-Wendtland R; Beckmann MW; Wachter DL
Breast Cancer Res Treat; 2012 Oct; 135(3):885-92. PubMed ID: 22936391
[TBL] [Abstract][Full Text] [Related]
2. Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study.
Heusinger K; Jud SM; Häberle L; Hack CC; Adamietz BR; Meier-Meitinger M; Lux MP; Wittenberg T; Wagner F; Loehberg CR; Uder M; Hartmann A; Schulz-Wendtland R; Beckmann MW; Fasching PA
Int J Cancer; 2012 Dec; 131(11):2643-9. PubMed ID: 22392346
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density, response to hormones, and breast cancer risk.
Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
[TBL] [Abstract][Full Text] [Related]
4. Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.
Hack CC; Emons J; Jud SM; Heusinger K; Adler W; Gass P; Haeberle L; Heindl F; Hein A; Schulz-Wendtland R; Uder M; Hartmann A; Beckmann MW; Fasching PA; Pöhls UG
Breast Cancer Res Treat; 2017 Dec; 166(3):701-708. PubMed ID: 28828694
[TBL] [Abstract][Full Text] [Related]
5. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer.
Ma H; Luo J; Press MF; Wang Y; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):479-85. PubMed ID: 19190139
[TBL] [Abstract][Full Text] [Related]
6. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in Tunisia: association of body mass index with histopathological aspects of tumors.
Bouguerra H; Guissouma H; Labidi S; Stambouli N; Marrakchi R; Chouaib S; Ben Ammar Elgaaied A; Boussen H; Gati A
Asian Pac J Cancer Prev; 2014; 15(16):6805-10. PubMed ID: 25169529
[TBL] [Abstract][Full Text] [Related]
8. Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Wunderle M; Pretscher J; Brucker SY; Volz B; Hartmann A; Fiessler C; Hein A; Häberle L; Jud SM; Lux MP; Janni W; Loehberg CR; Hartkopf AD; Walter CB; Baake G; Fridman A; Malter W; Wuerstlein R; Harbeck N; Hoffmann O; Kümmel S; Martin B; Thomssen C; Graf H; Wolf C; Bayer CM; Hack CC; Almstedt K; Gass P; Heindl F; Brodkorb TF; Nabieva N; Lindner C; Kolberg HC; Krabisch P; Weigel M; Steinfeld-Birg D; Kohls A; Brucker C; Schulz V; Fischer G; Pelzer V; Wallwiener D; Rack B; Fehm T; Rody A; Maass N; Beckmann MW; Fasching PA; Rauh C
Breast Cancer Res Treat; 2019 Apr; 174(2):453-461. PubMed ID: 30603996
[TBL] [Abstract][Full Text] [Related]
9. Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.
Hack CC; Stoll MJ; Jud SM; Heusinger K; Adler W; Haeberle L; Ganslandt T; Heindl F; Schulz-Wendtland R; Cavallaro A; Uder M; Beckmann MW; Fasching PA; Bayer CM
Cancer Med; 2017 Jun; 6(6):1473-1481. PubMed ID: 28464481
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
[TBL] [Abstract][Full Text] [Related]
11. Association of molecular subtypes with breast cancer risk factors: a case-only analysis.
Rauh C; Gass P; Heusinger K; Haeberle L; Jud SM; Hein A; Loehberg CR; Lux MP; Wachter DL; Heimrich J; Strehl JD; Haller F; Hartmann A; Schulz-Wendtland R; Fiessler C; Beckmann MW; Fasching PA; Poehls U
Eur J Cancer Prev; 2015 Nov; 24(6):484-90. PubMed ID: 25494290
[TBL] [Abstract][Full Text] [Related]
12. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.
Huo CW; Chew G; Hill P; Huang D; Ingman W; Hodson L; Brown KA; Magenau A; Allam AH; McGhee E; Timpson P; Henderson MA; Thompson EW; Britt K
Breast Cancer Res; 2015 Jun; 17(1):79. PubMed ID: 26040322
[TBL] [Abstract][Full Text] [Related]
13. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics.
Rice MS; Tamimi RM; Bertrand KA; Scott CG; Jensen MR; Norman AD; Visscher DW; Chen YY; Brandt KR; Couch FJ; Shepherd JA; Fan B; Wu FF; Ma L; Collins LC; Cummings SR; Kerlikowske K; Vachon CM
Breast Cancer Res Treat; 2018 Jul; 170(1):129-141. PubMed ID: 29502324
[TBL] [Abstract][Full Text] [Related]
14. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy, mammographic density, and breast cancer risk.
Martin LJ; Minkin S; Boyd NF
Maturitas; 2009 Sep; 64(1):20-6. PubMed ID: 19709825
[TBL] [Abstract][Full Text] [Related]
16. Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes.
Kleinstern G; Scott CG; Tamimi RM; Jensen MR; Pankratz VS; Bertrand KA; Norman AD; Visscher DW; Couch FJ; Brandt K; Shepherd J; Wu FF; Chen YY; Cummings SR; Winham S; Kerlikowske K; Vachon CM
Breast Cancer Res Treat; 2021 May; 187(1):215-224. PubMed ID: 33392844
[TBL] [Abstract][Full Text] [Related]
17. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.
Harvey JA; Santen RJ; Petroni GR; Bovbjerg VE; Smolkin ME; Sheriff FS; Russo J
Menopause; 2008; 15(1):67-73. PubMed ID: 17558338
[TBL] [Abstract][Full Text] [Related]
18. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying social inequality in post-menopausal breast cancer.
Hvidtfeldt UA
Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
[TBL] [Abstract][Full Text] [Related]
20. Physical activity and mammographic breast density in a Mediterranean population: the EPIC Florence longitudinal study.
Masala G; Assedi M; Ambrogetti D; Sera F; Salvini S; Bendinelli B; Ermini I; Giorgi D; Rosselli del Turco M; Palli D
Int J Cancer; 2009 Apr; 124(7):1654-61. PubMed ID: 19085933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
